Canadian Pain Society: Distinguished Career Award
Congratulations to Zymedyne’s Chief Science Office & Co-Founder, Dr. Gerald Zamponi for his long standing contributions to pain research and management! Link to the 2021 ASM Keynote: https://www.canadianpainsociety.ca/2021-ASM Source: @CanadianPain on Twitter
NAI Fellow – Dr. Zamponi
Zymedyne is very proud to congratulate Co-founder Dr. Gerald Zamponi on being inducted as Fellow of the 2020 class of National Academy of Inventors (#NAIFellow). Dr. Zamponi is being recognized for his innovation and research in developing and patenting treatments for chronic pain and epilepsy. Only two other Canadian academics out of a total of 175 inductees made the 2020 NAI list. Dr Zamponi will receive his award at the NAI Tenth Annual Meeting, June 8, 2021, in Tampa, Florida. Links: https://academyofinventors.org/ https://academyofinventors.org/wp-content/uploads/2020/12/2020-Fellows-Congratulatory.pdf
Campus Alberta Neuroscience Grant
Zymedyne Therapeutics is pleased to announce that it has been awarded an Entrepreneurship Seed grant from Campus Alberta Neuroscience (CAN).
IC Fellowship News Release
ZYMEDYNE awarded $200,000 Life Science fellowship from Innovate Calgary.